Carl Byrnes

Stock Analyst at Northland Capital Markets

(0.23)
# 2540
Out of 5,329 analysts
31
Total ratings
31.25%
Success rate
-0.41%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
BLFS BioLife Solns
Maintains: Outperform
28 31
25.27 22.68% 2 Jan 8, 2025
TLSI TriSalus Life Scienc...
Initiates Coverage On: Outperform
13
5.01 149.5% 1 Oct 25, 2024
BWAY BrainsWay
Maintains: Outperform
11 13
8.84 41.4% 3 Oct 3, 2024
ONCT Oncternal Therapeuti...
Downgrades: Market Perform
2
n/a n/a 1 Sep 12, 2024
MDAI Spectral AI
Initiates Coverage On: Outperform
6
1.27 372.44% 1 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
40 25
11.37 119.88% 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
0.43 1760.47% 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 1
n/a n/a 1 Dec 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 18
n/a n/a 2 Sep 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 80
22.49 255.71% 4 Aug 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9
n/a n/a 1 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
n/a n/a 1 Oct 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
6.33 263.35% 3 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
30 24
1.03 2230.1% 4 May 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
128
n/a n/a 1 Apr 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2000
1.3 153746.15% 1 Oct 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Sep 27, 2017